Skip to main content
. 2020 Sep 14;12(9):2615. doi: 10.3390/cancers12092615

Figure 4.

Figure 4

Follicle-stimulating hormone (FSH), luteinizing hormone (LH), total and free testosterone during mitotane therapy in male patients; * indicates statistical significance, Note: patients who were put on testosterone replacement were excluded from the analysis.